Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 353

1.

Preface: The energetic brain - a review from students to students.

Schulz JB, Hausmann L.

J Neurochem. 2019 Sep 15. doi: 10.1111/jnc.14836. [Epub ahead of print]

PMID:
31523808
2.

Cerebral changes improved by physical activity during cognitive decline: A systematic review on MRI studies.

Haeger A, Costa AS, Schulz JB, Reetz K.

Neuroimage Clin. 2019;23:101933. doi: 10.1016/j.nicl.2019.101933. Epub 2019 Jul 16. Review.

3.

Application of Quantitative Motor Assessments in Friedreich Ataxia and Evaluation of Their Relation to Clinical Measures.

Hohenfeld C, Dogan I, Schubert R, Didszun C, Schöls L, Synofzik M, Giordano IA, Klockgether T, Schulz JB, Reilmann R, Reetz K.

Cerebellum. 2019 Aug 22. doi: 10.1007/s12311-019-01073-x. [Epub ahead of print]

PMID:
31441004
4.

EPO regulates neuroprotective Transmembrane BAX Inhibitor-1 Motif-containing (TMBIM) family members GRINA and FAIM2 after cerebral ischemia-reperfusion injury.

Habib P, Stamm AS, Zeyen T, Noristani R, Slowik A, Beyer C, Wilhelm T, Huber M, Komnig D, Schulz JB, Reich A.

Exp Neurol. 2019 Oct;320:112978. doi: 10.1016/j.expneurol.2019.112978. Epub 2019 Jun 15.

PMID:
31211943
5.

Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar Ataxia.

Diallo A, Jacobi H, Cook A, Giunti P, Parkinson MH, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Castaldo A, Rakowicz M, Rola R, Sulek A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Boesch S, Nachbauer W, Pandolfo M, Schulz JB, Bauer P, Jun-Suk K, Klockgether T, Tezenas du Montcel S.

Mov Disord. 2019 Aug;34(8):1220-1227. doi: 10.1002/mds.27739. Epub 2019 Jun 18.

PMID:
31211461
6.

Atypical presentation of anti-Ma2-associated encephalitis with choreiform movement.

Lamby N, Leypoldt F, Schulz JB, Tauber SC.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 1;6(3):e557. doi: 10.1212/NXI.0000000000000557. eCollection 2019 May. No abstract available.

7.

Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.

Joseph S, Vingill S, Jahn O, Fledrich R, Werner HB, Katona I, Möbius W, Mitkovski M, Huang Y, Weis J, Sereda MW, Schulz JB, Nave KA, Stegmüller J.

J Neurosci. 2019 Jul 10;39(28):5606-5626. doi: 10.1523/JNEUROSCI.3094-18.2019. Epub 2019 May 13.

PMID:
31085610
8.

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors.

Hopfner F, Müller SH, Steppat D, Miller J, Schmidt N, Wandinger KP, Leypoldt F, Berg D, Franke A, Lieb W, Tittmann L, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Hilker-Roggendorf R, Kalbe E, Kassubek J, Klockgether T, Liepelt-Scarfone I, Mollenhauer B, Neuser P, Reetz K, Riedel O, Schulte C, Schulz JB, Spottke A, Storch A, Trenkwalder C, Wittchen HU, Witt K, Wüllner U, Deuschl G, Kuhlenbäumer G.

Transl Neurodegener. 2019 Apr 3;8:11. doi: 10.1186/s40035-019-0153-0. eCollection 2019.

9.

Neurogenic pulmonary edema following seizures: A retrospective computed tomography study.

Mahdavi Y, Surges R, Nikoubashman O, Olaciregui Dague K, Brokmann JC, Willmes K, Wiesmann M, Schulz JB, Matz O.

Epilepsy Behav. 2019 May;94:112-117. doi: 10.1016/j.yebeh.2019.02.006. Epub 2019 Mar 19.

PMID:
30901571
10.

Going beyond the mean: Intraindividual variability of cognitive performance in prodromal and early neurodegenerative disorders.

Costa AS, Dogan I, Schulz JB, Reetz K.

Clin Neuropsychol. 2019 Feb;33(2):369-389. doi: 10.1080/13854046.2018.1533587. Epub 2019 Jan 21.

PMID:
30663511
11.

Endovascular stroke treatment does not preclude high thrombolysis rates.

Feda S, Nikoubashman O, Schürmann K, Matz O, Tauber SC, Wiesmann M, Schulz JB, Reich A.

Eur J Neurol. 2019 Mar;26(3):428-e33. doi: 10.1111/ene.13831. Epub 2018 Nov 18.

PMID:
30317687
12.

Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.

Wojtala J, Heber IA, Neuser P, Heller J, Kalbe E, Rehberg SP, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker-Roggendorf R, Oberschmidt C, Baudrexel S, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen HU, Riedel O, Dodel R, Schulz JB, Reetz K.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):171-179. doi: 10.1136/jnnp-2018-319008. Epub 2018 Oct 8.

PMID:
30297519
13.

α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1-42-stimulated murine astrocytes.

Ebrahimi T, Rust M, Kaiser SN, Slowik A, Beyer C, Koczulla AR, Schulz JB, Habib P, Bach JP.

J Neuroinflammation. 2018 Sep 27;15(1):282. doi: 10.1186/s12974-018-1319-x.

14.

Monitoring α-synuclein multimerization in vivo.

Prasad V, Wasser Y, Hans F, Goswami A, Katona I, Outeiro TF, Kahle PJ, Schulz JB, Voigt A.

FASEB J. 2019 Feb;33(2):2116-2131. doi: 10.1096/fj.201800148RRR. Epub 2018 Sep 25.

PMID:
30252534
15.

Risk factors of suicidal ideation in Huntington's disease: literature review and data from Enroll-HD.

Honrath P, Dogan I, Wudarczyk O, Görlich KS, Votinov M, Werner CJ, Schumann B, Overbeck RT, Schulz JB, Landwehrmeyer BG, Gur RE, Habel U, Reetz K; Enroll-HD investigators.

J Neurol. 2018 Nov;265(11):2548-2561. doi: 10.1007/s00415-018-9013-6. Epub 2018 Aug 27. Review.

PMID:
30167880
16.

Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.

Komnig D, Dagli TC, Habib P, Zeyen T, Schulz JB, Falkenburger BH.

J Neurochem. 2018 Dec;147(5):678-691. doi: 10.1111/jnc.14575. Epub 2018 Nov 13.

PMID:
30152864
17.

Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS).

Reetz K, Dogan I, Hohenfeld C, Didszun C, Giunti P, Mariotti C, Durr A, Boesch S, Klopstock T, Rodríguez de Rivera Garrido FJ, Schöls L, Giordano I, Bürk K, Pandolfo M, Schulz JB; EFACTS Study Group.

Neurology. 2018 Sep 4;91(10):e917-e930. doi: 10.1212/WNL.0000000000006121. Epub 2018 Aug 10.

PMID:
30097477
18.

Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD).

Stankevich Y, Lueken U, Balzer-Geldsetzer M, Dodel R, Gräber-Sultan S, Berg D, Liepelt-Scarfone I, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O.

Am J Geriatr Psychiatry. 2018 Oct;26(10):1079-1090. doi: 10.1016/j.jagp.2018.06.012. Epub 2018 Jun 30.

PMID:
30082208
19.

Open Science Badges in the Journal of Neurochemistry.

Schweitzer B, Schulz JB.

J Neurochem. 2018 Oct;147(2):132-136. doi: 10.1111/jnc.14536. Epub 2018 Aug 1.

PMID:
30069885
20.

Characterization of Naïve and Vitamin C-Treated Mouse Schwann Cell Line MSC80: Induction of the Antioxidative Thioredoxin Related Transmembrane Protein 1.

Phan V, Schmidt J, Matyash V, Malchow S, Thanisch M, Lorenz C, Diepolder I, Schulz JB, Stenzel W, Roos A, Gess B.

J Proteome Res. 2018 Sep 7;17(9):2925-2936. doi: 10.1021/acs.jproteome.8b00022. Epub 2018 Aug 10.

PMID:
30044099
21.

The discriminative value of blood gas analysis parameters in the differential diagnosis of transient disorders of consciousness.

Olaciregui Dague K, Surges R, Litmathe J, Villa L, Brokmann J, Schulz JB, Dafotakis M, Matz O.

J Neurol. 2018 Sep;265(9):2106-2113. doi: 10.1007/s00415-018-8967-8. Epub 2018 Jul 9.

PMID:
29987588
22.

Modern Interdisciplinary and Interhospital Acute Stroke Therapy-What Patients Think About It and What They Really Understand.

Pressler H, Reich A, Schulz JB, Nikoubashman O, Willmes K, Habib P, Bach JP.

J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2669-2676. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.029. Epub 2018 Jun 30.

PMID:
29970323
23.

Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.

Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Sarro L, Rakowicz M, Sulek A, Sobanska A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Szymanski S, Boesch S, Nachbauer W, Kang JS, Pandolfo M, Schulz JB, Melac AT, Diallo A, Klockgether T.

J Neurol. 2018 Sep;265(9):2040-2051. doi: 10.1007/s00415-018-8954-0. Epub 2018 Jun 29.

PMID:
29959555
24.

Structural characteristics of the central nervous system in Friedreich ataxia: an in vivo spinal cord and brain MRI study.

Dogan I, Romanzetti S, Didszun C, Mirzazade S, Timmann D, Saft C, Schöls L, Synofzik M, Giordano IA, Klockgether T, Schulz JB, Reetz K.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):615-617. doi: 10.1136/jnnp-2018-318422. Epub 2018 Jun 26. No abstract available.

PMID:
29945881
25.

Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial.

Lenssen R, Schmitz K, Griesel C, Heidenreich A, Schulz JB, Trautwein C, Marx N, Fitzner C, Jaehde U, Eisert A.

BMC Geriatr. 2018 Jun 4;18(1):135. doi: 10.1186/s12877-018-0814-3.

26.

Impact of gender and genetics on emotion processing in Parkinson's disease - A multimodal study.

Heller J, Mirzazade S, Romanzetti S, Habel U, Derntl B, Freitag NM, Schulz JB, Dogan I, Reetz K.

Neuroimage Clin. 2018 Jan 31;18:305-314. doi: 10.1016/j.nicl.2018.01.034. eCollection 2018.

27.

Correction to: Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model.

Drinkut A, Tillack K, Meka DP, Schulz JB, Kügler S, Kramer ER.

Cell Death Dis. 2018 May 25;9(6):634. doi: 10.1038/s41419-018-0636-4.

28.

FYCO1 mediates clearance of α-synuclein aggregates through a Rab7-dependent mechanism.

Saridaki T, Nippold M, Dinter E, Roos A, Diederichs L, Fensky L, Schulz JB, Falkenburger BH.

J Neurochem. 2018 Aug;146(4):474-492. doi: 10.1111/jnc.14461. Epub 2018 Jul 23.

29.

Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.

Diallo A, Jacobi H, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sobanska A, Sulek A, Schmitz-Hübsch T, Schöls L, Hengel H, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Boesch S, Pandolfo M, Schulz JB, Bauer P, Giunti P, Kang JS, Klockgether T, Tezenas du Montcel S.

Lancet Neurol. 2018 Apr;17(4):327-334. doi: 10.1016/S1474-4422(18)30042-5. Epub 2018 Mar 13.

PMID:
29553382
30.

Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2.

Reetz K, Rodríguez-Labrada R, Dogan I, Mirzazade S, Romanzetti S, Schulz JB, Cruz-Rivas EM, Alvarez-Cuesta JA, Aguilera Rodríguez R, Gonzalez Zaldivar Y, Auburger G, Velázquez-Pérez L.

Ann Clin Transl Neurol. 2018 Jan 7;5(2):128-137. doi: 10.1002/acn3.504. eCollection 2018 Feb.

31.

Relevance of standard intravenous thrombolysis in endovascular stroke therapy of a tertiary stroke center.

Heinrichs A, Nikoubashman O, Schürmann K, Tauber SC, Wiesmann M, Schulz JB, Reich A.

Acta Neurol Belg. 2018 Mar;118(1):105-111. doi: 10.1007/s13760-018-0892-1. Epub 2018 Feb 12.

PMID:
29435828
32.

Reviewer selection biases editorial decisions on manuscripts.

Hausmann L, Schweitzer B, Middleton FA, Schulz JB.

J Neurochem. 2018 Jan 27. doi: 10.1111/jnc.14314. [Epub ahead of print]

33.

Faim2 contributes to neuroprotection by erythropoietin in transient brain ischemia.

Komnig D, Gertz K, Habib P, Nolte KW, Meyer T, Brockmann MA, Endres M, Rathkolb B, Hrabě de Angelis M; German Mouse Clinic Consortium, Schulz JB, Falkenburger BH, Reich A.

J Neurochem. 2018 May;145(3):258-270. doi: 10.1111/jnc.14296. Epub 2018 Feb 20.

34.

Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements.

Tanguy Melac A, Mariotti C, Filipovic Pierucci A, Giunti P, Arpa J, Boesch S, Klopstock T, Müller Vom Hagen J, Klockgether T, Bürk K, Schulz JB, Reetz K, Pandolfo M, Durr A, Tezenas du Montcel S; EFACTS group.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):559-565. doi: 10.1136/jnnp-2017-316964. Epub 2017 Dec 26.

PMID:
29279305
35.

Anterior sacral meningocele infected with Fusobacterium in a patient with recently diagnosed colorectal carcinoma - a case report.

Braczynski AK, Brockmann MA, Scholz T, Bach JP, Schulz JB, Tauber SC.

BMC Neurol. 2017 Dec 8;17(1):212. doi: 10.1186/s12883-017-0992-1.

36.

Mechanistic contributions of FBXO7 to Parkinson disease.

Joseph S, Schulz JB, Stegmüller J.

J Neurochem. 2018 Jan;144(2):118-127. doi: 10.1111/jnc.14253. Epub 2017 Dec 11. Review.

37.

Unobtrusive Nocturnal Heartbeat Monitoring by a Ballistocardiographic Sensor in Patients with Sleep Disordered Breathing.

Zink MD, Brüser C, Stüben BO, Napp A, Stöhr R, Leonhardt S, Marx N, Mischke K, Schulz JB, Schiefer J.

Sci Rep. 2017 Oct 13;7(1):13175. doi: 10.1038/s41598-017-13138-0.

38.

Clinical and biometrical 12-month follow-up in patients after reconstruction of the sural nerve biopsy defect by the collagen-based nerve guide Neuromaix.

Bozkurt A, Claeys KG, Schrading S, Rödler JV, Altinova H, Schulz JB, Weis J, Pallua N, van Neerven SGA.

Eur J Med Res. 2017 Sep 22;22(1):34. doi: 10.1186/s40001-017-0279-4.

39.

Frequent genes in rare diseases: panel-based next generation sequencing to disclose causal mutations in hereditary neuropathies.

Dohrn MF, Glöckle N, Mulahasanovic L, Heller C, Mohr J, Bauer C, Riesch E, Becker A, Battke F, Hörtnagel K, Hornemann T, Suriyanarayanan S, Blankenburg M, Schulz JB, Claeys KG, Gess B, Katona I, Ferbert A, Vittore D, Grimm A, Wolking S, Schöls L, Lerche H, Korenke GC, Fischer D, Schrank B, Kotzaeridou U, Kurlemann G, Dräger B, Schirmacher A, Young P, Schlotter-Weigel B, Biskup S.

J Neurochem. 2017 Dec;143(5):507-522. doi: 10.1111/jnc.14217. Epub 2017 Nov 7.

40.

Early postictal serum lactate concentrations are superior to serum creatine kinase concentrations in distinguishing generalized tonic-clonic seizures from syncopes.

Matz O, Heckelmann J, Zechbauer S, Litmathe J, Brokmann JC, Willmes K, Schulz JB, Dafotakis M.

Intern Emerg Med. 2018 Aug;13(5):749-755. doi: 10.1007/s11739-017-1745-2. Epub 2017 Sep 12.

PMID:
28900842
41.

Vaccination strategies in tauopathies and synucleinopathies.

Braczynski AK, Schulz JB, Bach JP.

J Neurochem. 2017 Dec;143(5):467-488. doi: 10.1111/jnc.14207. Epub 2017 Oct 16. Review.

42.

Cognitive Improvement and Brain Changes after Real-Time Functional MRI Neurofeedback Training in Healthy Elderly and Prodromal Alzheimer's Disease.

Hohenfeld C, Nellessen N, Dogan I, Kuhn H, Müller C, Papa F, Ketteler S, Goebel R, Heinecke A, Shah NJ, Schulz JB, Reske M, Reetz K.

Front Neurol. 2017 Aug 9;8:384. doi: 10.3389/fneur.2017.00384. eCollection 2017.

43.

Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression.

Diallo A, Jacobi H, Schmitz-Hübsch T, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sobanska A, Sulek A, Schöls L, Hengel H, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Boesch S, Pandolfo M, Schulz JB, Bauer P, Giunti P, Baliko L, Parkinson MH, Kang JS, Klockgether T, Tezenas du Montcel S.

Mov Disord Clin Pract. 2017 Aug 11;4(5):689-697. doi: 10.1002/mdc3.12522. eCollection 2017 Sep-Oct.

44.

The malleable brain - An educational review from students to students.

Schulz JB, Hausmann L.

J Neurochem. 2017 Sep;142(6):788-789. doi: 10.1111/jnc.14102. Epub 2017 Aug 8.

45.

Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.

Cordts I, Bodart N, Hartmann K, Karagiorgou K, Tzartos JS, Mei L, Reimann J, Van Damme P, Rivner MH, Vigneron A, Weis J, Schulz JB, Tzartos SJ, Claeys KG.

J Neurol. 2017 Jun;264(6):1193-1203. doi: 10.1007/s00415-017-8514-z. Epub 2017 May 17.

PMID:
28516329
46.

Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, Van Damme P, Ferbert A, Petri S, Hartmann C, Bornemann A, Meisel A, Petersen JA, Tousseyn T, Thal DR, Reimann J, De Jonghe P, Martin JJ, Van den Bergh PY, Schulz JB, Weis J, Claeys KG.

Orphanet J Rare Dis. 2017 May 11;12(1):86. doi: 10.1186/s13023-017-0640-2. Review.

47.

Sodium-dependent Vitamin C transporter 2 deficiency impairs myelination and remyelination after injury: Roles of collagen and demethylation.

Röhr D, Halfter H, Schulz JB, Young P, Gess B.

Glia. 2017 Jul;65(7):1186-1200. doi: 10.1002/glia.23152. Epub 2017 Apr 29.

PMID:
28456003
48.

Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease.

Lueken U, Evens R, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Gräber-Sultan S, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O.

Int J Methods Psychiatr Res. 2017 Dec;26(4). doi: 10.1002/mpr.1564. Epub 2017 Apr 18.

PMID:
28418163
49.

Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP).

Hube L, Dohrn MF, Karsai G, Hirshman S, Van Damme P, Schulz JB, Weis J, Hornemann T, Claeys KG.

PLoS One. 2017 Jan 23;12(1):e0170583. doi: 10.1371/journal.pone.0170583. eCollection 2017.

50.

Linking amyotrophic lateral sclerosis and spinal muscular atrophy through RNA-transcriptome homeostasis: a genomics perspective.

Gama-Carvalho M, L Garcia-Vaquero M, R Pinto F, Besse F, Weis J, Voigt A, Schulz JB, De Las Rivas J.

J Neurochem. 2017 Apr;141(1):12-30. doi: 10.1111/jnc.13945. Epub 2017 Feb 28. Review.

Supplemental Content

Loading ...
Support Center